S-1: PACS Group Eyes Further Growth with Secondary Offering

PACS Group, a leading post-acute healthcare company, is undertaking a secondary offering of common stock to repay debt and support future expansion.

Summary

• PACS Group is offering 2,777,778 shares of common stock, while selling stockholders are offering 11,111,112 shares.
• The company will not receive any proceeds from the sale of shares by the selling stockholders.
• The offering aims to repay a portion of the amounts outstanding under the company's Amended and Restated 2023 Credit Facility.
• Following the offering, the founders will continue to hold a significant majority of the voting power.
• The company is a controlled company within the meaning of the New York Stock Exchange corporate governance standards.
• Investing in the company's common stock involves risks, as detailed in the prospectus.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook for PACS Group, highlighting its strong performance metrics and growth strategy. However, it also acknowledges several risks and challenges, including regulatory scrutiny, competition, and reliance on government reimbursements. The sentiment is moderately positive, reflecting a balanced view of the company's prospects.

Positives

• The company has a high average QM Star rating compared to the industry average.
• Mature facilities have a high average occupancy rate compared to the industry average.
• The company has a disciplined acquisition strategy.
• The company has a decentralized, market-driven operating model.
• The company has a transparent and meritocratic leadership culture.
• The company has a robust suite of technology-enabled services.

Negatives

• The founders will continue to have substantial control over the company after the offering.
• The company is a controlled company and may elect to rely on exemptions from certain corporate governance standards.
• Affiliates of the underwriters will receive at least 5% of the net proceeds, creating a conflict of interest.

Risks

• The company depends upon reimbursement from third-party payors, and changes in payor mix and payment methodologies could negatively impact results.
• Increased competition for nurses and other skilled personnel could increase staffing costs.
• The company is subject to various government and third-party payor reviews, audits and investigations.
• The company is subject to litigation, which is commonplace in the industry.
• The company relies significantly on information technology, and any failure could harm the business.
• The company may be unable to complete future acquisitions at attractive prices.
• The company leases the majority of its facilities, subjecting it to risks associated with leased real property.
• The company operates in a highly regulated industry with stringent regulatory compliance obligations.
• The company has broad discretion in how it may use the net proceeds from this offering.
• The founders have entered into margin loans and pledged a portion of their shares of our common stock as collateral to secure such margin loans.

Future Outlook

The company anticipates that available acquisition opportunities will enable it to further penetrate existing states and enter new states in the future. The company intends to continue to selectively exercise purchase options and continue structuring additional purchase options to provide an additional lever to grow net margins and enhance stockholder value.

Management Comments

• The company believes its operating model delivers value to all of its healthcare stakeholders.
• The company believes that healthcare is local and operates through a decentralized model.
• The company believes that talented local leadership is critical to the success of its model.
• The company is committed to providing a high-quality experience for all of its patients.

Industry Context

The SNF industry is large and growing, with CMS expecting total industry expenditures to increase from $209.3 billion in 2023 to $337.4 billion in 2032, representing a compound annual growth rate (CAGR) of 5.4%. The industry is highly fragmented, with the top 10 operators representing approximately 11% of the total number of SNFs in the United States.

Comparison to Industry Standards

• The company's average QM Star rating across all facilities was 4.3 Stars as of June 30, 2024, compared to the industry average of 3.5 Stars.
• The company's average occupancy rate across Mature facilities was 94% for the six months ended June 30, 2024, compared to the industry average of 76%.
• MedPAC reports that SNFs are the lowest cost facility-based post-acute healthcare, costing an average of $550 per covered day compared to $1,850 and $1,753 per covered day for inpatient rehabilitation facilities and long-term acute care hospitals, respectively.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Employees may benefit from the company's growth and investment in training.
• Patients and families may benefit from the company's focus on quality care.
• Payors may benefit from the company's cost-effective care delivery.
• Referring providers may benefit from the company's ability to care for higher acuity patients.

Next Steps

• The underwriters expect to deliver the shares of common stock to purchasers on or about a specified date in 2024.
• The company intends to use the net proceeds to repay amounts outstanding under its Amended and Restated 2023 Credit Facility.
• The company plans to continue to strategically pursue acquisition opportunities.
• The company intends to invest heavily in training existing leaders and expanding its bench of new administrators and RVPs to support future growth.
• The company plans to continue to evaluate its real estate purchase options.

Key Dates

Keywords

skilled nursing facilities, post-acute care, Medicare, Medicaid, acquisitions, occupancy rate, QM Star rating, reimbursement, healthcare, SNF